About: Fletikumab

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Fletikumab (NNC0109-0012) (INN) is a monoclonal antibody designed for the treatment of rheumatoid arthritis that targets IL-20. This drug was being developed by Novo Nordisk A/S until Novo ceased work in inflammation.

Property Value
dbo:abstract
  • Fletikumab (NNC0109-0012) (INN) is a monoclonal antibody designed for the treatment of rheumatoid arthritis that targets IL-20. This drug was being developed by Novo Nordisk A/S until Novo ceased work in inflammation. (en)
dbo:casNumber
  • 1357158-22-5
dbo:chEMBL
  • 3301580
dbo:fdaUniiCode
  • 82WG3POL9W
dbo:kegg
  • D11756
dbo:wikiPageID
  • 46643744 (xsd:integer)
dbo:wikiPageLength
  • 2206 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1048080705 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • none (en)
dbp:c
  • 6494 (xsd:integer)
dbp:casNumber
  • 1357158 (xsd:integer)
dbp:chembl
  • 3301580 (xsd:integer)
dbp:chemspiderid
  • none (en)
dbp:h
  • 10000 (xsd:integer)
dbp:kegg
  • D11756 (en)
dbp:n
  • 1728 (xsd:integer)
dbp:o
  • 2050 (xsd:integer)
dbp:s
  • 44 (xsd:integer)
dbp:synonyms
  • NNC0109-0012 (en)
dbp:target
dbp:type
  • mab (en)
dbp:unii
  • 82 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Fletikumab (NNC0109-0012) (INN) is a monoclonal antibody designed for the treatment of rheumatoid arthritis that targets IL-20. This drug was being developed by Novo Nordisk A/S until Novo ceased work in inflammation. (en)
rdfs:label
  • Fletikumab (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License